Page-3 of Remdesivir Current Affairs, GK & News

Cipla’s ‘Cipremi’ gets approval for Treatment of COVID-19 Patients in India

In its June 13th, 2020 guidelines for Clinical Management Protocol for COVID-19, the Union Health Ministry as a part of investigational therapy added ‘Remdesivir’ only for restricted emergency use. A week after, on 21st June 2020, Hetero and Cipla Pharmaceuticals were granted approval by the Drug Controller General of India for the production and marketing ..

Month: 

Category: 

Topics: 

Hetero’s injectable ‘Covifor’ gets DCGI approval for COVID-19 Treatment

For the treatment of COVID-19 positive cases, on 21st June 2020, Hyderabad based pharmaceutical company -Hetero Drugs has received approval from the Drug Controller General of India (a department under- CDSCO: Central Drugs Standard Control Organization) for manufacturing and marketing of antiviral drug Remdesivir. Brandname for Marketing Under the brand name ‘Covifor’, Hetero Pharmaceuticals’ generic ..

Month: 

Category: 

Topics: 

Remdesivir now a part of COVID-19 therapy in new health protocol

The Union Health Ministry has recently included Remdesivir as a part of investigational therapy and updated Clinical Management Protocol of COVID-19 patients. The ministry has also added loss of taste and loss of smell as two key symptoms of COVID-19 infection. The Ministry recently issued “Clinical Management Protocols for COVID-19”. The above therapies and protocols ..

Month: 

Category: 

Topics: 

WHO suspended Hydroxycloroquine trials

The World Health Organization recently suspended its trials on the efficacy of the drug Hydroxychloroquine in treating COVID-19. The HCQ trial is one of the four mega trials initiated by the organization. Mega Trials The four mega trials include HCQ, Lopinavir and Ritonavir, Lopinavir and Ritonavir along with Interferon and Remdesivir. India’s Current Status After ..

Month: 

Category: 

Topics: 

US to donate Ventilators to India

The United States recently announced that it will donate ventilators to India. The announcement is seen as a reciprocal gesture of India’s lift on the export ban of the anti-malarial drug Hydroxychloroquine. Hydroxychloroquine India recently lifted the export ban over HCQ drugs. This benefitted the United States to larger extent. Also, US being one of ..

Month: 

Category: 

Topics: